Your browser doesn't support javascript.
loading
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor.
Harrold, Leslie R; Reed, George W; Kremer, Joel M; Curtis, Jeffrey R; Solomon, Daniel H; Hochberg, Marc C; Greenberg, Jeffrey D.
Afiliação
  • Harrold LR; University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Reed GW; University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Kremer JM; Albany Medical College, Albany, New York, USA.
  • Curtis JR; Department of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Solomon DH; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Hochberg MC; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Greenberg JD; Department of Rheumatology, New York University Hospital for Joint Diseases, New York, USA.
Ann Rheum Dis ; 74(2): 430-6, 2015 Feb.
Article em En | MEDLINE | ID: mdl-24297378

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Imunoconjugados / Antirreumáticos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Imunoconjugados / Antirreumáticos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos